San Diego—In hematologic malignancies, chimeric antigen receptor (CAR)-modified T cells will be increasingly combined with other therapeutic strategies, according to multiple studies presented at the 2018 annual meeting of the…

In chronic myelogenous leukemia (CML) patients taking a tyrosine kinase inhibitor (TKI), earlier initiation of molecular testing is associated with lower treatment costs and less likelihood of disease progression, according…

Malnutrition is a condition seen all over the world, not just in developing nations. In the United States, food deserts (areas without access to high-quality food) exist in rural and…

Ten years ago, Swedish researchers reported that bariatric surgery was associated with a dramatically reduced the incidence of cancer in women but not in men. Now, a new American study…

San Diego—Last fall, brentuximab vedotin (BV) was approved as part of a combination for the first-line treatment of CD30-expressing peripheral T-cell lymphomas (PTCLs)—even before the full data from a registration…